Latest Registration Statement Stories

BLUE BELL, Pa., March 12, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it has closed an underwritten offering of 27,377,266 shares of its common stock and warrants to purchase up to 13,688,633 shares of common stock at a combined price of $0.55 per share and related warrant for gross proceeds of $15.1 million. The warrants are exercisable at an exercise price of $.7936 per share and will expire, unless exercised, on the date that is 180 days...

WINNIPEG, March 12, 2013 /PRNewswire/ - IMRIS Inc. ("IMRIS" or the "Company") (NASDAQ: IMRS; TSX: IM) today announced that it has commenced an underwritten public offering of its common shares.  The offering is being conducted in the United States pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission (the "SEC") and in Canada pursuant to a final short form base shelf prospectus filed with the securities regulatory...

ATHENS, Greece, March 12, 2013 /PRNewswire/ -- Box Ships Inc. (NYSE:TEU) today announced that it intends to offer and sell $25,000,000 of its common shares in an underwritten public offering. The Company intends to grant the underwriters a 30-day option to purchase an additional $3,750,000 of its common shares to cover over-allotments, if any. The net proceeds of the offering are expected to be used by the Company for general corporate purposes, which may include the repayment...

HOUSTON, March 12, 2013 /PRNewswire/ -- MRC Global Inc. (NYSE:MRC) announced today the closing of the offering of 26.45 million shares of the company's common stock by PVF Holdings LLC, a selling stockholder, at a price to the public of $28.00 per share in a registered underwritten public offering. The 26.45 million shares sold in the offering include shares issued upon the exercise by the underwriters of their option to purchase an additional 3.45 million shares. The company will...

SAN JOSE, Calif., March 11, 2013 /PRNewswire/ -- Maxim Integrated Products, Inc. (NASDAQ:MXIM) today announced the offering and pricing of $500 million of its 3.375% Senior Notes due 2023. Subject to market conditions and other factors, Maxim Integrated intends to use the net proceeds from this offering to repurchase shares of its common stock and for general corporate purposes. Maxim Integrated will use its cash on hand to redeem, repurchase or repay at maturity all of its...

BOULDER, Colo., March 11, 2013 /PRNewswire/ -- Rally®, a leading provider of cloud-based solutions for managing Agile software development, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Deutsche Bank Securities Inc. and Piper...

FRAMINGHAM, Mass. and SYDNEY, March 11, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) ("HeartWare") announced today its intention to offer, subject to market and other conditions, 1,500,000 shares of common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). HeartWare also intends to grant the underwriters an option to purchase up to an additional 225,000 shares to cover over-allotments,...

CHICAGO, March 11, 2013 /PRNewswire/ -- Aviv REIT, Inc. ("Aviv" or the "Company") announced today that it has commenced an initial public offering of 13,200,000 shares of its common stock. The estimated price range of the common stock is between $18.00 and $20.00 per share. The underwriters have the option to purchase up to an additional 1,980,000 shares of common stock to cover overallotments, if any. The Company's common stock has been approved for listing on the New York Stock...

RESEARCH TRIANGLE PARK, N.C., March 8, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not been determined. Morgan...

SUNNYVALE, Calif., March 8, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC), a clinical stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases, today announced the pricing of a previously announced underwritten registered public offering of 2,200,000 shares of its common stock, representing approximately 3.1% of the shares of common stock currently outstanding, at a...